Expired Study
This study is not currently recruiting Study Participants on ClinicalConnection.com. If you would like to find active studies please search for clinical trials.

McLean, Virginia 22102


Purpose:

The study is a prospective multi-centered cohort study designed to determine the safety and efficacy of AlloMax in immediate expander-based breast reconstruction. Specifically, the study is designed to determine if sterility of human acellular dermal matrix results in a lower incidence of infection and seroma. The study will determine if gamma radiation, as a method of terminally sterilizing human acellular dermal matrix, has a negative impact on graft incorporation into the host tissue.


Criteria:

Inclusion Criteria: - Patients having immediate breast reconstruction with tissue expanders - Unilateral or bilateral reconstructions - Ages 25 - 65 - All breast cancer stages and types Exclusion Criteria: - BMI > 35 - Active smokers - Diabetics - History of radiation or planned radiation - Immunocompromised patients


NCT ID:

NCT01372917


Primary Contact:

N/A


Backup Contact:

N/A


Location Contact:

McLean, Virginia 22102
United States



There is no listed contact information for this specific location.

Site Status: N/A


Data Source: ClinicalTrials.gov

Date Processed: August 31, 2019

Modifications to this listing: Only selected fields are shown, please use the link below to view all information about this clinical trial.


Click to view Full Listing

This study is not currently recruiting Study Participants on ClinicalConnection.com. The form below is not enabled.